Severe bronchopulmonary dysplasia in extremely premature infants: a scoping review protocol for identifying risk factors.

Shin KatoMasato ItoMakoto SaitoNaoyuki MiyaharaFumihiko NambaErika OtaHidehiko Nakanishi

Published in: BMJ open (2022)

Institutional review board approval is not required due to the nature of the study. The results of this review will be disseminated through peer-reviewed publications and presentations at relevant conferences.Protocol V.1, 22 September 2021 TRIAL REGISTRATION NUMBER: UMIN000045529.

Keyphrases

risk factors
randomized controlled trial
study protocol
clinical trial
phase iii
drug induced